CN107582576A - A kind of composition with biological inflammation-diminishing function and preparation method thereof - Google Patents
A kind of composition with biological inflammation-diminishing function and preparation method thereof Download PDFInfo
- Publication number
- CN107582576A CN107582576A CN201710942840.3A CN201710942840A CN107582576A CN 107582576 A CN107582576 A CN 107582576A CN 201710942840 A CN201710942840 A CN 201710942840A CN 107582576 A CN107582576 A CN 107582576A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- epa
- haematococcus pluvialis
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Disclosed by the invention is a kind of composition with biological inflammation-diminishing function and preparation method thereof, including following components mix：Haematococcus pluvialis spore powder with crushed sporoderm, DHA algal oil, EPA, vitamin C, vitamin E；Haematococcus pluvialis water soluble powder or Astaxanthin In Haematococcus Pluvialis oil, DHA algal oil, EPA, vitamin C, vitamin E；Haematococcus pluvialis water soluble powder, DHA algal oil, EPA, vitamin C, vitamin E, D-sorbite, magnesium stearate, citric acid, flavoring essence；Astaxanthin In Haematococcus Pluvialis oil, DHA algal oil, EPA, vitamin C, vitamin E, monoglyceride, sucrose ester, soybean lecithin, essence, sweetener, pure water, the present invention can effectively suppress inflammatory cytokine and chemotactic factor (CF), reduce inflammation caused swelling, alleviate the inflammatory conditions such as arthritis, gastritis, composition green natural, it is easily manufactured, it can be made into a variety of formulations, absorption efficiency is high, and human body is had no toxic side effect.
Description
Technical field
The present invention relates to a kind of composition and preparation method thereof, more a little says, being related to one kind has biological inflammation-diminishing function
Composition and preparation method thereof.
Background technology
At present, the antiphlogistic of in the market is mostly chemical synthesis or steroids, and malicious pair can occur for the use for them
Effect, it is particularly the most serious to the toxic side effect of kidney organ, more universal bad of antiphlogistic of in the market is taken at present
Hair should have Nausea and vomiting and dizzy etc., a kind of composition with biological inflammation-diminishing function provided by the invention, possess the work of anti-inflammatory
With, while have the characteristics of safe and free of toxic and side effects concurrently, for people provide it is a it is brand-new have no toxic side effect, it is safe and reliable
Anti-inflammatory product.
The content of the invention
It is an object of the invention to provide with have no toxic side effect, strengthen immunity, one kind of the technical characterstic such as anti-infective
Composition with biological inflammation-diminishing function.
Another object of the present invention is to provide a kind of preparation method of the composition with biological inflammation-diminishing function.
The present invention is to be achieved through the following technical solutions：
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：40-4000 parts
Haematococcus pluvialis spore powder with crushed sporoderm, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-10 part vitamins
E。
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：25-2000 parts
Haematococcus pluvialis water soluble powder or 20-2000 parts Astaxanthin In Haematococcus Pluvialis oil, 20-1000 part DHA algal oils, 2-100 part EPA,
30-800 part vitamin Cs, 2-10 part vitamin Es.
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：25-2000 parts
Haematococcus pluvialis water soluble powder, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-10 part vitamin Es,
120-4900 part D-sorbites, 0.2-50 part magnesium stearates, 1-5 part citric acids, 1-10 part flavoring essences.
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：20-2000 parts
Astaxanthin In Haematococcus Pluvialis oil, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-10 part vitamin Es,
1-300 part monoglycerides, 1-300 part sucrose esters, 1-300 part soybean lecithins, 2-200 part essence, 1-30 part sweeteners, 1000-
99900 parts of pure water.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 40-4000 part haematococcus pluvialis spore powder with crushed sporoderm, 20-1000 part DHA algal oils, 2-
100 parts of EPA, 30-800 part vitamin C, the mixing of 2-10 parts vitamin E, stir, obtain mixture A；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains hard shell capsules.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 25-2000 part haematococcus pluvialis water soluble powders or 20-2000 part haematococcus pluvialis
Astaxanthin oil, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, the mixing of 2-10 parts vitamin E, stirring are equal
It is even, obtain mixture B；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains soft capsule.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 25-2000 part haematococcus pluvialis water soluble powders, 20-1000 part DHA algal oils, 2-
100 parts of EPA, 30-800 part vitamin C, 2-10 part vitamin Es, 120-4900 part D-sorbites, 0.2-50 part magnesium stearates, 1-
5 parts of citric acids, the mixing of 1-10 parts flavoring essence, stir, obtain mixture C；
Step 2)：The mixture C tabletting that step 1) is obtained, obtain candy.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, 20-2000 parts Astaxanthin In Haematococcus Pluvialis oil is emulsified, obtains astaxanthin emulsion,
20-1000 parts DHA algal oil is emulsified, obtains DHA emulsions, 2-100 parts EPA is emulsified, EPA emulsions are obtained, by astaxanthin
Emulsion, DHA emulsions, EPA emulsions are well mixed, and obtain mix emulsion fluid；
Step 2)：By mass fraction, by 30-800 part vitamin Cs, 2-10 part vitamin Es, 1-300 part monoglycerides, 1-300
Part sucrose ester, 1-300 part soybean lecithins, 2-200 part essence, 1-30 part sweeteners, the mixing of 1000-99900 parts pure water, and
It is added in the mix emulsion fluid of step 1) acquisition, is mixed evenly, obtains oral liquid.
Beneficial effect：The characteristics of with anti-inflammatory and having no toxic side effect, for people provide it is a it is brand-new have no toxic side effect,
Safe and reliable anti-inflammatory product；Inflammatory cytokine and chemotactic factor (CF) can effectively be suppressed, reduce inflammation caused swelling, alleviates and closes
The inflammatory conditions such as inflammation, gastritis are saved, it has equal or higher effect compared with 92% anti-inflammatory drug；Formula is simple, and composition is green
Color is natural, easily manufactured, can be made into a variety of formulations, and absorption efficiency is high；；Each component mass fraction scope accurately controls so that disappears
Scorching, anti-infective, raising immunity is in optimum value, if departing from the mass fraction scope used between each component of the present invention, anti-inflammatory, resists
Downward trend is presented in infection, the effect of raising immunity, thereby increases and it is possible to occurs without any anti-inflammatory, anti-infectious effect.
Astaxanthin In Haematococcus Pluvialis has a variety of physiological functions, such as in anti-oxidant, anti-inflammatory, strengthen immunity, anti-infective
Aspect has good effect, and for natural astaxanthin compared with 26 kinds of famous anti-inflammatory drugs, astaxanthin is taken in as a result display
The health status of patient improves 85%, and natural astaxanthin has equal effect or better with 92% anti-inflammatory drug, but
It is free from side effects, can effectively alleviates the inflammatory conditions such as arthritis, preventing and treating rheumatism bone disease effect is fabulous, and it takes simultaneously with aspirin
With its drug effect can be strengthened；
DHA algal oil has the formation for suppressing inflammation precursor, has the function that anti-inflammatory；
Treatments of the EPA to big enterelcosis and regional ileitis can all play a positive role；
Vitamin C is High Primates animal and the essential nutrients of other a small number of biologies；
Vitamin E is a kind of liposoluble vitamin, and its hydrolysate is tocopherol, and main function is antioxidant.
Embodiment
Below by way of specific embodiment, the present invention is further illustrated, but embodiments of the present invention not by
The limitation of following examples.
Embodiment 1
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：40 parts of rain lifes
Haematococcus spore powder with crushed sporoderm, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts of vitamin Cs, 2 parts of vitamin Es.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 40 parts of haematococcus pluvialis spore powder with crushed sporoderm, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts
Vitamin C, 2 parts of vitamin E mixing, stir, obtain mixture A；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains hard shell capsules.
Embodiment 2
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：2020 parts of rain
Raw haematococcus spore powder with crushed sporoderm, 510 parts of DHA algal oils, 51 parts of EPA, 415 parts of vitamin Cs, 6 parts of vitamin Es.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 2020 parts of haematococcus pluvialis spore powder with crushed sporoderm, 510 parts of DHA algal oils, 51 parts of EPA,
415 parts of vitamin Cs, 6 parts of vitamin E mixing, stir, obtain mixture A；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains ebonite bellows.
Embodiment 3
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：25 parts of rain lifes
Haematococcus water soluble powder or 20 parts of Astaxanthin In Haematococcus Pluvialis oil, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts of vitamin Cs, 2 parts of dimension lifes
Plain E.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 25 parts of haematococcus pluvialis water soluble powders or 20 parts of Astaxanthin In Haematococcus Pluvialis oil, 20
Part DHA algal oil, 2 parts of EPA, 30 parts of vitamin Cs, 2 parts of vitamin Es mixing, stir, obtain mixture B；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains soft capsule.
Embodiment 4
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：1012 parts of rain
Raw haematococcus water soluble powder or 1010 parts of Astaxanthin In Haematococcus Pluvialis oil, 510 parts of DHA algal oils, 51 parts of EPA, 415 parts of vitamin Cs,
6 parts of vitamin Es.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 1012 parts of haematococcus pluvialis water soluble powders or 1010 parts of Astaxanthin In Haematococcus Pluvialis
Oil, 510 parts of DHA algal oils, 51 parts of EPA, 415 parts of vitamin Cs, 6 parts of vitamin E mixing, stir, obtain mixture B；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains soft capsule.
Embodiment 5
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：25 parts of rain lifes
Haematococcus water soluble powder, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts of vitamin Cs, 2 parts of vitamin Es, 120 parts of D-sorbites, 0.2 part
Magnesium stearate, 1 part of citric acid, 1 part of flavoring essence.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 25 parts of haematococcus pluvialis water soluble powders, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts of dimensions
Raw plain C, 2 parts of vitamin Es, 120 parts of D-sorbites, 0.2 part of magnesium stearate, 1 part of citric acid, 1 part of flavoring essence mixing, stirring are equal
It is even, obtain mixture C；
Step 2)：The mixture C tabletting that step 1) is obtained, obtain candy.
Embodiment 6
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：1012 parts of rain
Raw haematococcus water soluble powder, 510 parts of DHA algal oils, 51 parts of EPA, 415 parts of vitamin Cs, 6 parts of vitamin Es, 2510 parts of D-sorbites,
25.1 parts of magnesium stearates, 3 parts of citric acids, 5.5 parts of flavoring essences.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 1012 parts of haematococcus pluvialis water soluble powders, 510 parts of DHA algal oils, 51 parts of EPA, 415
Part vitamin C, 6 parts of vitamin Es, 2510 parts of D-sorbites, 25.1 parts of magnesium stearates, 3 parts of citric acids, 5.5 parts of flavoring essences mix
Close, stir, obtain mixture C；
Step 2)：The mixture C tabletting that step 1) is obtained, obtain candy.
Embodiment 7
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：20 parts of rain lifes
Haematococcus astaxanthin oil, 20 parts of DHA algal oils, 2 parts of EPA, 30 parts of vitamin Cs, 2 parts of vitamin Es, 1 part of monoglyceride, 1 part of sucrose ester,
1 part of soybean lecithin, 2 parts of essence, 1 part of sweetener, 1000 parts of pure water.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 20 parts of Astaxanthin In Haematococcus Pluvialis oil emulsifications, astaxanthin emulsion is obtained, by 20
Part DHA algal oil emulsification, obtains DHA emulsions, 2 parts of EPA is emulsified, obtain EPA emulsions, by astaxanthin emulsion, DHA emulsifications
Liquid, EPA emulsions are well mixed, and obtain mix emulsion fluid；
Step 2)：It is by mass fraction, 30 parts of vitamin Cs, 2 parts of vitamin Es, 1 part of monoglyceride, 1 part of sucrose ester is 1 part big
Beans lecithin, 2 parts of essence, 1 part of sweetener, 1000 parts of pure water mixing, and be added in the mix emulsion fluid of step 1) acquisition,
It is mixed evenly, sterilizes, obtains oral liquid.
Embodiment 8
A kind of composition with biological inflammation-diminishing function, mixed by mass fraction including following components：1010 parts of rain
Raw haematococcus astaxanthin oil, 1010 parts of DHA algal oils, 51 parts of EPA, 415 parts of vitamin Cs, 6 parts of vitamin Es, 150 parts of monoglycerides,
150 parts of sucrose esters, 150 parts of soybean lecithins, 101 parts of essence, 15 parts of sweeteners, 50000 parts of pure water.
A kind of preparation method of the composition with biological inflammation-diminishing function, including following preparation process：
Step 1)：By mass fraction, by 1010 parts of Astaxanthin In Haematococcus Pluvialis oil emulsifications, astaxanthin emulsion is obtained, will
The emulsification of 1010 parts of DHA algal oils, obtains DHA emulsions, and 51 parts of EPA are emulsified, and obtains EPA emulsions, by astaxanthin emulsion,
DHA emulsions, EPA emulsions are well mixed, and obtain mix emulsion fluid；
Step 2)：By mass fraction, by 415 parts of vitamin Cs, 6 parts of vitamin Es, 150 parts of monoglycerides, 150 parts of sucrose esters,
150 parts of soybean lecithins, 101 parts of essence, 15 parts of sweeteners, 50000 parts of pure water mixing, and it is added to the mixed of step 1) acquisition
Close in emulsion, be mixed evenly, sterilize, obtain oral liquid.
Finally it should be noted that the invention is not restricted to above example, there can also be many variations.This area it is general
All deformations that logical technical staff directly can export or associate from present disclosure, it is considered as the present invention's
Protection domain.
Claims (8)
1. a kind of composition with biological inflammation-diminishing function, it is characterised in that mixed by mass fraction including following components：
40-4000 part haematococcus pluvialis spore powder with crushed sporoderm, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-
10 parts of vitamin Es.
2. a kind of composition with biological inflammation-diminishing function, it is characterised in that mixed by mass fraction including following components：
25-2000 part haematococcus pluvialis water soluble powders or 20-2000 parts Astaxanthin In Haematococcus Pluvialis oil, 20-1000 part DHA algal oils, 2-
100 parts of EPA, 30-800 part vitamin C, 2-10 part vitamin Es.
3. a kind of composition with biological inflammation-diminishing function, it is characterised in that mixed by mass fraction including following components：
25-2000 part haematococcus pluvialis water soluble powders, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-10
Part vitamin E, 120-4900 part D-sorbites, 0.2-50 part magnesium stearates, 1-5 part citric acids, 1-10 part flavoring essences.
4. a kind of composition with biological inflammation-diminishing function, it is characterised in that mixed by mass fraction including following components：
20-2000 parts Astaxanthin In Haematococcus Pluvialis oil, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, 2-10
Part vitamin E, 1-300 part monoglycerides, 1-300 part sucrose esters, 1-300 part soybean lecithins, 2-200 part essence, 1-30 part sweet teas
Taste agent, 1000-99900 part pure water.
A kind of 5. preparation method of the composition with biological inflammation-diminishing function as claimed in claim 1, it is characterised in that including
Following preparation process：
Step 1)：By mass fraction, by 40-4000 part haematococcus pluvialis spore powder with crushed sporoderm, 20-1000 part DHA algal oils, 2-100
Part EPA, 30-800 part vitamin Cs, the mixing of 2-10 parts vitamin E, stir, obtain mixture A；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains hard shell capsules.
A kind of 6. preparation method of the composition with biological inflammation-diminishing function as claimed in claim 2, it is characterised in that including
Following preparation process：
Step 1)：It is by mass fraction, 25-2000 part haematococcus pluvialis water soluble powders or 20-2000 part haematococcus pluvialis shrimp is blue or green
Vegetable oil, 20-1000 part DHA algal oils, 2-100 parts EPA, 30-800 part vitamin C, the mixing of 2-10 parts vitamin E, stir,
Obtain mixture B；
Step 2)：The mixture A that step 1) obtains is wrapped up through capsule material, obtains soft capsule.
A kind of 7. preparation method of the composition with biological inflammation-diminishing function as claimed in claim 3, it is characterised in that including
Following preparation process：
Step 1)：By mass fraction, by 25-2000 part haematococcus pluvialis water soluble powders, 20-1000 part DHA algal oils, 2-100 parts
EPA, 30-800 part vitamin C, 2-10 part vitamin Es, 120-4900 part D-sorbites, 0.2-50 part magnesium stearates, 1-5 part lemons
Lemon acid, the mixing of 1-10 parts flavoring essence, stir, obtain mixture C；
Step 2)：The mixture C tabletting that step 1) is obtained, obtain candy.
A kind of 8. preparation method of the composition with biological inflammation-diminishing function as claimed in claim 4, it is characterised in that including
Following preparation process：
Step 1)：By mass fraction, 20-2000 parts Astaxanthin In Haematococcus Pluvialis oil is emulsified, obtains astaxanthin emulsion, will
20-1000 parts DHA algal oil is emulsified, and obtains DHA emulsions, and 2-100 parts EPA is emulsified, and obtains EPA emulsions, by astaxanthin breast
Change liquid, DHA emulsions, EPA emulsions to be well mixed, obtain mix emulsion fluid；
Step 2)：By mass fraction, by 30-800 part vitamin Cs, 2-10 part vitamin Es, 1-300 part monoglycerides, 1-300 part sugarcanes
Sugar ester, 1-300 part soybean lecithins, 2-200 part essence, 1-30 part sweeteners, the mixing of 1000-99900 parts pure water, and add
In the mix emulsion fluid obtained to step 1), it is mixed evenly, sterilizes, obtains oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710942840.3A CN107582576A (en) | 2017-10-11 | 2017-10-11 | A kind of composition with biological inflammation-diminishing function and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710942840.3A CN107582576A (en) | 2017-10-11 | 2017-10-11 | A kind of composition with biological inflammation-diminishing function and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107582576A true CN107582576A (en) | 2018-01-16 |
Family
ID=61053847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710942840.3A Pending CN107582576A (en) | 2017-10-11 | 2017-10-11 | A kind of composition with biological inflammation-diminishing function and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107582576A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110638040A (en) * | 2019-10-31 | 2020-01-03 | 杭州鑫伟低碳技术研发有限公司 | A product prepared from Haematococcus pluvialis for preventing and treating senile dementia, and its preparation method |
| CN111194918A (en) * | 2020-01-07 | 2020-05-26 | 杭州鑫伟低碳技术研发有限公司 | Nutrient composition for improving mitochondrial metabolism and relieving sports fatigue |
| CN111281857A (en) * | 2018-12-07 | 2020-06-16 | 株式会社日健总本社 | Capsule preparation |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109712A (en) * | 1993-12-20 | 1995-10-11 | 三荣源Ffi株式会社(此公司为公知) | Stable emulsifying composition and food with same |
| CN102258191A (en) * | 2010-12-23 | 2011-11-30 | 天津天狮生物发展有限公司 | Antioxidative health-care food for preventing chronic inflammation and preparation method thereof |
| CN102884434A (en) * | 2010-05-12 | 2013-01-16 | 希尔氏宠物营养品公司 | Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
| CN104905321A (en) * | 2015-05-27 | 2015-09-16 | 中国科学院天津工业生物技术研究所 | Wall-breaking Haematoccoccus Pluvialis powder microcapsules and preparation process thereof |
| CN106689618A (en) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | Astaxanthin tabletting candy preparation method |
-
2017
- 2017-10-11 CN CN201710942840.3A patent/CN107582576A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109712A (en) * | 1993-12-20 | 1995-10-11 | 三荣源Ffi株式会社(此公司为公知) | Stable emulsifying composition and food with same |
| CN102884434A (en) * | 2010-05-12 | 2013-01-16 | 希尔氏宠物营养品公司 | Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
| CN102258191A (en) * | 2010-12-23 | 2011-11-30 | 天津天狮生物发展有限公司 | Antioxidative health-care food for preventing chronic inflammation and preparation method thereof |
| CN104905321A (en) * | 2015-05-27 | 2015-09-16 | 中国科学院天津工业生物技术研究所 | Wall-breaking Haematoccoccus Pluvialis powder microcapsules and preparation process thereof |
| CN106689618A (en) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | Astaxanthin tabletting candy preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 李妍等: ""EPA与DHA最新研究进展"", 《农产品加工.学刊》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111281857A (en) * | 2018-12-07 | 2020-06-16 | 株式会社日健总本社 | Capsule preparation |
| CN110638040A (en) * | 2019-10-31 | 2020-01-03 | 杭州鑫伟低碳技术研发有限公司 | A product prepared from Haematococcus pluvialis for preventing and treating senile dementia, and its preparation method |
| CN111194918A (en) * | 2020-01-07 | 2020-05-26 | 杭州鑫伟低碳技术研发有限公司 | Nutrient composition for improving mitochondrial metabolism and relieving sports fatigue |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| JP2006296226A (en) | Fucoidan-containing food and drink | |
| CN107582576A (en) | A kind of composition with biological inflammation-diminishing function and preparation method thereof | |
| CN104664370A (en) | Chewable flax tablet | |
| CN106975069A (en) | A kind of liver protecting composition and preparation method thereof | |
| JP2016532446A (en) | Enbu fermented food or beverage composition | |
| CN105876435A (en) | Anti-oxidizing composition soft capsule and preparation method thereof | |
| WO2008059965A1 (en) | Agent for alleviating or preventing stress symptoms and agent for improving mental conditions | |
| CN111838500A (en) | Ginseng pine needle effervescent tablet and preparation method thereof | |
| CN101496573A (en) | Garlic oil soft capsule | |
| CN104000216A (en) | Prebiotics water-soluble dietary fiber and preparation method thereof | |
| CN107772190A (en) | A kind of Astaxanthin In Haematococcus Pluvialis product formula for improving puerpera and infant immunity | |
| CN101869297A (en) | Compound evening primrose and perilla herb oil fat emulsion oral solution, beverage and preparation method | |
| JP2023036051A (en) | Preventative or ameliorating agent for mental fatigue | |
| JP2007014281A (en) | Liquid food composition ingestible by spraying and method for producing the same | |
| JP2019135217A (en) | Powder composition, method for producing powder composition, dry eye improving agent, skin quality improving agent, food and drink, cosmetic, and pet food | |
| KR20220118257A (en) | Powder For Candyfloss Containing Functional Food | |
| RU2419446C1 (en) | Composition of dense extract of conifer needles for capsulation | |
| CN108366600A (en) | For the method for the lotion with ω -3 to be prepared and stablized by the equiaxed crystal network of cellulose derivative | |
| CN101744242A (en) | Composite soft capsule using seabuckthorm seed oil and evening primrose seed oil as main raw material and making method | |
| CN101214053A (en) | Health-care beverage | |
| JP2016082959A (en) | Functional food product, and tablet or capsule tablet having viewing function improvement effect containing blueberry | |
| JP6860917B2 (en) | Emulsified composition for preventing or improving snoring | |
| JP3210193U (en) | A tablet or capsule tablet of a food composition for improving intestinal absorption. | |
| JP2018093846A (en) | Food composition for improving intestinal absorption amount of lutein and anthocyanin, and tablet or capsule tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180116 |
|
| RJ01 | Rejection of invention patent application after publication |